Glancy prongay & murray llp, a leading securities fraud law firm, announces investigation of nrx pharmaceuticals, inc. (nrxp) on behalf of investors

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of nrx pharmaceuticals, inc. (“nrx” or the “company”) (nasdaq: nrxp) investors concerning the company's possible violations of the federal securities laws. if you suffered a loss on your nrx investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities law
NRXP Ratings Summary
NRXP Quant Ranking